It's Now Even Easier to Prescribe HCV Treatments
#OctoberIs4Livers - Liver Cancer Awareness Month
#OctoberIs4Livers is a global campaign to raise awareness of liver cancer and Hepatitis Queensland is…Read Article
What are the barriers stopping someone getting tested for hepatitis C?
Since the introduction of direct-acting antivirals (DAAs) on the Pharmaceutical Benefits Scheme (PBS) in 2016,…Read Article
Hepatitis C testing: Who do we need to test?
Nationally there has been a push to increase the number of people who are being…Read Article
Changes to the Pharmaceutical Benefits Scheme (PBS) from 1st April mean:
- virus genotype is no longer required before prescribing treatment, and
- the 18+ age restriction has also been removed.
Pangenotypic treatments, available under the PBS, are suitable for all hepatitis C genotypes. GPs can find more information about treating hepatitis C on our GP Resources page.